DK0699103T3 - Overflademodificerede, biokompatible membraner - Google Patents
Overflademodificerede, biokompatible membranerInfo
- Publication number
- DK0699103T3 DK0699103T3 DK94916437T DK94916437T DK0699103T3 DK 0699103 T3 DK0699103 T3 DK 0699103T3 DK 94916437 T DK94916437 T DK 94916437T DK 94916437 T DK94916437 T DK 94916437T DK 0699103 T3 DK0699103 T3 DK 0699103T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- modified
- biocompatible membranes
- sec
- date
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0081—After-treatment of organic or inorganic membranes
- B01D67/0093—Chemical modification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
- A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
- B01D67/0011—Casting solutions therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
- B01D67/0016—Coagulation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
- B01D67/0016—Coagulation
- B01D67/00165—Composition of the coagulation baths
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/08—Specific temperatures applied
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/12—Specific ratios of components used
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO931809A NO931809L (no) | 1993-05-19 | 1993-05-19 | Hemofilter |
PCT/NO1994/000088 WO1994026399A1 (en) | 1993-05-19 | 1994-05-09 | Surface modified biocompatible membranes |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0699103T3 true DK0699103T3 (da) | 2004-04-05 |
Family
ID=19896100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94916437T DK0699103T3 (da) | 1993-05-19 | 1994-05-09 | Overflademodificerede, biokompatible membraner |
Country Status (14)
Country | Link |
---|---|
US (1) | US5840190A (de) |
EP (1) | EP0699103B1 (de) |
JP (1) | JPH08510166A (de) |
AT (1) | ATE254953T1 (de) |
AU (1) | AU672708B2 (de) |
BR (1) | BR9406410A (de) |
CA (1) | CA2162495A1 (de) |
DE (1) | DE69433356T2 (de) |
DK (1) | DK0699103T3 (de) |
ES (1) | ES2211881T3 (de) |
FI (1) | FI955525A (de) |
NO (1) | NO931809L (de) |
PT (1) | PT699103E (de) |
WO (1) | WO1994026399A1 (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5304220A (en) * | 1991-07-03 | 1994-04-19 | Maginot Thomas J | Method and apparatus for implanting a graft prosthesis in the body of a patient |
US20020156523A1 (en) * | 1994-08-31 | 2002-10-24 | Lilip Lau | Exterior supported self-expanding stent-graft |
US6331188B1 (en) * | 1994-08-31 | 2001-12-18 | Gore Enterprise Holdings, Inc. | Exterior supported self-expanding stent-graft |
DE19514104C2 (de) * | 1995-04-13 | 1997-05-28 | Behringwerke Ag | Beschichtung für in den Blutstrom oder in das Gewebe des menschlichen Körpers einbringbares Biomaterial |
CA2258732C (en) * | 1996-06-20 | 2006-04-04 | Sulzer Vascutek Ltd. | Prosthetic repair of body passages |
US6551350B1 (en) * | 1996-12-23 | 2003-04-22 | Gore Enterprise Holdings, Inc. | Kink resistant bifurcated prosthesis |
FR2772639B1 (fr) | 1997-12-24 | 2000-02-04 | Hospal Ind | Utilisation d'un polymere neutre ou cationique pour prevenir l'activation de la phase contact du sang ou du plasma en contact avec une membrane semi-permeable |
US6221425B1 (en) * | 1998-01-30 | 2001-04-24 | Advanced Cardiovascular Systems, Inc. | Lubricious hydrophilic coating for an intracorporeal medical device |
FR2804328B1 (fr) * | 2000-01-27 | 2002-03-15 | Hospal Ind | Membrane semi-permeable non thrombogene et procede de fabrication |
US7670468B2 (en) | 2000-02-17 | 2010-03-02 | Applied Materials, Inc. | Contact assembly and method for electrochemical mechanical processing |
US6848970B2 (en) | 2002-09-16 | 2005-02-01 | Applied Materials, Inc. | Process control in electrochemically assisted planarization |
US6991528B2 (en) | 2000-02-17 | 2006-01-31 | Applied Materials, Inc. | Conductive polishing article for electrochemical mechanical polishing |
US7029365B2 (en) * | 2000-02-17 | 2006-04-18 | Applied Materials Inc. | Pad assembly for electrochemical mechanical processing |
US7678245B2 (en) | 2000-02-17 | 2010-03-16 | Applied Materials, Inc. | Method and apparatus for electrochemical mechanical processing |
US20050287560A1 (en) * | 2001-07-13 | 2005-12-29 | Nanosphere, Inc. | Method for preparing substrates having immobilized molecules and substrates |
US7297553B2 (en) * | 2002-05-28 | 2007-11-20 | Nanosphere, Inc. | Method for attachment of silylated molecules to glass surfaces |
US7687437B2 (en) | 2001-07-13 | 2010-03-30 | Nanosphere, Inc. | Method for immobilizing molecules onto surfaces |
US7407668B2 (en) * | 2002-01-24 | 2008-08-05 | Boston Scimed, Inc. | Medical articles having enzymatic surfaces for localized therapy |
SE527054C2 (sv) * | 2002-04-23 | 2005-12-13 | Gambro Lundia Ab | Förfarande för framställning av ett regioselektivt membran |
DE102004008219B3 (de) * | 2004-02-19 | 2005-10-27 | Membrana Gmbh | Integral asymmetrische Membran, Verfahren zu ihrer Herstellung und ihre Verwendung |
JP5036315B2 (ja) * | 2004-11-05 | 2012-09-26 | 株式会社カネカ | 血液接触材料の改質方法、及び顆粒球活性化が抑制された血液接触材料 |
BRPI0619820A2 (pt) | 2005-12-13 | 2011-10-18 | Exthera Ab | método de remoção extracorpórea de um micróbio patogênico, uma célula inflamatória ou uma proteìna inflamatória do sangue |
US20080135481A1 (en) * | 2006-12-06 | 2008-06-12 | General Electric Company | Polyarylethernitrile hollow fiber membranes |
US20110168631A1 (en) * | 2006-12-15 | 2011-07-14 | General Electric Company | Methods and apparatuses for water filtration using polyarylether membranes |
US7681741B2 (en) * | 2006-12-15 | 2010-03-23 | General Electric Company | Functional polyarylethers |
US7669720B2 (en) * | 2006-12-15 | 2010-03-02 | General Electric Company | Functional polyarylethers |
US7977451B2 (en) * | 2006-12-15 | 2011-07-12 | General Electric Company | Polyarylether membranes |
WO2008157570A2 (en) | 2007-06-18 | 2008-12-24 | Exthera Ab | Device and method for restoration of the condition of blood |
WO2008155683A1 (en) | 2007-06-18 | 2008-12-24 | Firmenich Sa | Malodor counteracting compositions and method for their use |
CN100548456C (zh) * | 2007-08-29 | 2009-10-14 | 浙江大学 | 一种亲和性丙烯腈基共聚物超细纤维膜的制备方法和应用 |
US20090069790A1 (en) * | 2007-09-07 | 2009-03-12 | Edward Maxwell Yokley | Surface properties of polymeric materials with nanoscale functional coating |
US8962097B1 (en) | 2007-09-07 | 2015-02-24 | Edward Maxwell Yokley | Surface properties of polymeric materials with nanoscale functional coating |
DE102008000220A1 (de) * | 2008-02-01 | 2009-08-13 | ASCALON Gesellschaft für Innovation in der Medizintechnik m.b.H. | Hohlfaser-Separationsmembranen und Verfahren zu ihrer Herstellung |
US20100222489A1 (en) * | 2009-02-27 | 2010-09-02 | Jiang Dayue D | Copolymer composition, membrane article, and methods thereof |
US8758286B2 (en) | 2009-12-01 | 2014-06-24 | Exthera Medical Corporation | Method for removing cytokines from blood with surface immobilized polysaccharides |
FR2960783B1 (fr) | 2010-06-04 | 2012-07-27 | Ass Pour Les Transferts De Technologies Du Mans | Membrane fonctionnalisee pour chambre d'encapsulation de cellules produisant au moins une substance d'interet therapeutique et organe bioartificiel comprenant une telle membrane |
WO2012112724A1 (en) | 2011-02-15 | 2012-08-23 | Exthera Medical, Llc | Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines |
DK2861273T3 (da) | 2012-06-13 | 2017-11-27 | Exthera Medical Corp | Anvendelse af heparin og kulhydrater til behandling af cancer. |
EP3013445B1 (de) | 2013-06-24 | 2019-11-06 | ExThera Medical Corporation | Blutfiltrationssystem mit mannosebeschichtetem substrat |
JP6806563B2 (ja) | 2013-11-08 | 2021-01-06 | エクステラ・メディカル・コーポレーション | 吸着媒体を使用する感染症の診断法 |
JP6344666B2 (ja) * | 2013-12-09 | 2018-06-27 | エルジー ハウスホールド アンド ヘルスケア リミテッド | カルボジイミド系化合物を含む組成物 |
BR112016024569B1 (pt) | 2014-04-24 | 2023-01-03 | Exthera Medical Corporation | Método ex vivo para remover bactérias de uma amostra retirada de um indivíduo que é suspeito de estar infectado com a mesma |
AU2015321601B2 (en) | 2014-09-22 | 2020-04-23 | Exthera Medical Corporation | Wearable hemoperfusion device |
EP3422943A4 (de) | 2016-03-02 | 2019-10-16 | ExThera Medical Corporation | Verfahren zur behandlung von arzneimittelintoxikation |
US11911551B2 (en) | 2016-03-02 | 2024-02-27 | Exthera Medical Corporation | Method for treating drug intoxication |
EP3680005A1 (de) | 2019-01-10 | 2020-07-15 | Gambro Lundia AB | Membran mit immobilisiertem anticoagulans und verfahren zu ihrer herstellung |
EP3981505A1 (de) | 2020-10-12 | 2022-04-13 | Gambro Lundia AB | Membran mit immobilisiertem antikoagulans und verfahren zu ihrer herstellung |
CN115120787B (zh) * | 2022-06-30 | 2023-06-23 | 上海翊科聚合物科技有限公司 | 一种血液透析复合膜制备方法及应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3441142A (en) * | 1966-07-21 | 1969-04-29 | Dow Chemical Co | Nonthrombogenic plastic membranes |
US3522346A (en) * | 1968-05-31 | 1970-07-28 | Research Corp | Nonthrombogenic microcapsules |
US3616935A (en) * | 1970-02-05 | 1971-11-02 | Dow Chemical Co | Preparation of antithrombogenic surfaces |
US3705084A (en) * | 1970-03-18 | 1972-12-05 | Monsanto Co | Macroporous enzyme reactor |
US4102746A (en) * | 1975-08-29 | 1978-07-25 | Amerace Corporation | Immobilized proteins |
US4702840A (en) * | 1982-02-05 | 1987-10-27 | Pall Corporation | Charge modified polyamide membrane |
SE8200751L (sv) * | 1982-02-09 | 1983-08-10 | Olle Larm | Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter |
US4906375A (en) * | 1984-07-14 | 1990-03-06 | Fresenius, Ag | Asymmetrical microporous hollow fiber for hemodialysis |
US4757014A (en) * | 1985-11-08 | 1988-07-12 | Minnesota Mining And Manufacturing Company | Immobilization of biologically active protein on a polymeric fibrous support |
GB8915974D0 (en) * | 1989-07-12 | 1989-08-31 | Gore W L & Ass Uk | Hydrophilic semi-permeable ptfe membranes and their manufacture |
US5096585A (en) * | 1991-01-28 | 1992-03-17 | W. R. Grace & Co.-Conn. | Process for preparing protein non-adsorptive microporous polysulfone membranes |
US5283186A (en) * | 1991-12-31 | 1994-02-01 | Abbott Laboratories | Preparation of a compressed membrane containing immobilized biologically acting material |
DE4238389A1 (de) * | 1992-11-13 | 1994-05-19 | Bayer Ag | Verfahren zur Durchführung immundiagnostischer Nachweise |
US5476665A (en) * | 1994-04-13 | 1995-12-19 | Minnesota Mining And Manufacturing Company | Azlactone functional particles incorporated in a membrane formed by solvent phase inversion |
-
1993
- 1993-05-19 NO NO931809A patent/NO931809L/no unknown
-
1994
- 1994-05-09 PT PT94916437T patent/PT699103E/pt unknown
- 1994-05-09 EP EP94916437A patent/EP0699103B1/de not_active Expired - Lifetime
- 1994-05-09 AT AT94916437T patent/ATE254953T1/de active
- 1994-05-09 AU AU68169/94A patent/AU672708B2/en not_active Expired
- 1994-05-09 DK DK94916437T patent/DK0699103T3/da active
- 1994-05-09 JP JP6525281A patent/JPH08510166A/ja active Pending
- 1994-05-09 BR BR9406410A patent/BR9406410A/pt not_active Application Discontinuation
- 1994-05-09 US US08/557,066 patent/US5840190A/en not_active Expired - Lifetime
- 1994-05-09 DE DE69433356T patent/DE69433356T2/de not_active Expired - Lifetime
- 1994-05-09 CA CA002162495A patent/CA2162495A1/en not_active Abandoned
- 1994-05-09 ES ES94916437T patent/ES2211881T3/es not_active Expired - Lifetime
- 1994-05-09 WO PCT/NO1994/000088 patent/WO1994026399A1/en active IP Right Grant
-
1995
- 1995-11-16 FI FI955525A patent/FI955525A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
DE69433356T2 (de) | 2004-08-26 |
FI955525A0 (fi) | 1995-11-16 |
NO931809D0 (no) | 1993-05-19 |
EP0699103A1 (de) | 1996-03-06 |
NO931809L (no) | 1994-11-21 |
ES2211881T3 (es) | 2004-07-16 |
ATE254953T1 (de) | 2003-12-15 |
BR9406410A (pt) | 1995-12-19 |
PT699103E (pt) | 2004-04-30 |
EP0699103B1 (de) | 2003-11-26 |
JPH08510166A (ja) | 1996-10-29 |
DE69433356D1 (de) | 2004-01-08 |
FI955525A (fi) | 1995-11-16 |
US5840190A (en) | 1998-11-24 |
AU6816994A (en) | 1994-12-12 |
WO1994026399A1 (en) | 1994-11-24 |
AU672708B2 (en) | 1996-10-10 |
CA2162495A1 (en) | 1994-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0699103T3 (da) | Overflademodificerede, biokompatible membraner | |
KR100263555B1 (de) | ||
AU3506893A (en) | Use of fullerenes in diagnostic and/or therapeutic agents | |
GB2289637B (en) | Flexible elastomeric article with enhanced lubricity | |
NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
IL117697A0 (en) | Polysiloxane-comprising perfluoroalkyl ethers and the preparation and use thereof | |
DE69508192D1 (de) | Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen | |
DE59509848D1 (de) | Kombinationspräparat zur anwendung bei immunologischen erkrankungen | |
ATE211636T1 (de) | Methode zum herstellen eines dentalproduktes | |
EP0525795A3 (en) | Use of fluorinated polyurethanes for the treatment of films or sheets made of cellulose, graphite, mica, kaolin, leather and similar natural materials | |
ATE83641T1 (de) | Implantierter durchgang. | |
ZA981780B (en) | The use of levobupivacaine in paediatric surgery | |
ATE204021T1 (de) | Klonierung, expression und charakterisierung einer neuen form der phosphatidylinositol-3- kinase | |
ATE169060T1 (de) | Lactobacillus sake ähnliche stämme herstellung und verwendung von deren exopolysacchariden | |
ZA849576B (en) | 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases | |
ATE200624T1 (de) | Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis | |
ATE209647T1 (de) | Pyridiniumsalze und ihre verwendung zur bekämpfung von helicobacter-bakterien | |
DE69930419D1 (de) | Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie | |
DE69319140T2 (de) | 4-guanidinobutyramid zur verbesserung des blutkreislaufs | |
NO954644L (no) | Overflate-modifiserte biokompatible membraner | |
NO984965L (no) | Komponent B som cicatrisant | |
ATE86497T1 (de) | Verwendung von igf-i zur herstellung eines praeparats fuer die behandlung und die verhuetung von nebeneffekten von hyperinsulinemia bei diabetikern behandelt mit insulin. | |
ATE76302T1 (de) | Verwendung von einer immunstimulanten biologisten substanz zur herstellung eines medikaments zur behandlung des menschlichen immunschwaechevirus. | |
ZA915627B (en) | The class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties,and vaccines containing same |